close
Skip to main content
Springer Nature Link
Log in

Functional diversity of ventral midbrain dopamine and GABAergic neurons

  • Published:
Save article
View saved research
BERJAYA Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Recent findings indicate that VTA and SN dopaminergic (DA) and GABAergic neurons form subpopulations that are divergent in their electrophysiological features, vulnerability to neurodegeneration, and regulation by neuropeptides. This diversity can be correlated with the anatomical organization of the VTA and SN and their inputs and outputs. In this review we describe the heterogeneity in ion channels and firing patterns, especially burst firing, in subpopulations of dopamine neurons. We go on to describe variations in vulnerability to neurotoxic damage in models of Parkinson’s disease in subgroups of DA neurons and its possible relationship to developmental gene regulation, the expression of different ion channels, and the expression of different protein markers, such as the neuroprotective marker calbindin. The electrophysiological properties of subgroups of GABAergic midbrain neurons, patterns of expression of protein markers and receptors, possible involvement of GABAergic neurons in a number of processes that are usually attributed exclusively to dopaminergic neurons, and the characteristics of a subgroup of neurons that contains both dopamine and GABA are also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.

References

  1. Fallon J.H. and Loughlin S.E. (1995) Substantia nigra. In The Rat Nervous System (Paxinos G., ed.), Academic Press, New York pp. 215–238.

    Google Scholar 

  2. Lacey M.G., Mercuri N.B. and North R.A. (1989) Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J. Neurosci. 9, 1233–1241.

    PubMed  CAS  Google Scholar 

  3. Johnson S.W. and North R.A. (1992) Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. Lond. 450, 455–468.

    PubMed  CAS  Google Scholar 

  4. Kita T., Kita H., and Kitai S.T. (1986) Electrical membrane properties of rat substantia nigra compacta neurons in an in vitro slice preparation. Brain Res. 372, 21–30.

    PubMed  CAS  Google Scholar 

  5. Grace A.A. and Bunney B.S. (1980) Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence. Science 210, 654–656.

    PubMed  CAS  Google Scholar 

  6. Wightman R.M. and Zimmerman J.B. (1990) Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res. Brain Res. Rev. 15, 135–144.

    PubMed  CAS  Google Scholar 

  7. Schultz W. (1998) Predictive reward signal of dopamine neurons. J. Neurophysiol. 80, 1–27.

    PubMed  CAS  Google Scholar 

  8. Schultz W. (2002) Getting formal with dopamine and reward. Neuron 36, 241–263.

    PubMed  CAS  Google Scholar 

  9. Horvitz J.C. (2000) Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience 96, 651–656.

    PubMed  CAS  Google Scholar 

  10. Grenhoff J., Ugedo L., and Svensson T.H. (1988) Firing patterns of midbrain dopamine neurons: differences between A9 and A10 cells. Acta Physiol. Scand. 134, 127–132.

    PubMed  CAS  Google Scholar 

  11. Hyland B.I., Reynolds J.N., Hay J., Perk C.G., and Miller R. (2002) Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 114, 475–492.

    PubMed  CAS  Google Scholar 

  12. Overton P.G. and Clark D. (1997) Burst firing in midbrain dopaminergic neurons. Brain Res. Brain Res. Rev. 25, 312–334.

    PubMed  CAS  Google Scholar 

  13. Johnson S.W., Seutin V., and North R.A. (1992) Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump. Science 258, 665–667.

    PubMed  CAS  Google Scholar 

  14. Seutin V., Johnson S.W., and North R.A. (1993) Apamin increases NMDA-induced burst-firing of rat mesencephalic dopamine neurons. Brain Res. 630, 341–344.

    PubMed  CAS  Google Scholar 

  15. Kohler M., Hirschberg B., Bond C.T., Kinzie J.M., Marrion N.V., Maylie J., et al. (1996) Small-conductance, calcium-activated potassium channels from mammalian brain. Science 273, 1709–1714.

    PubMed  CAS  Google Scholar 

  16. Mourre C., Schmid-Antomarchi H., Hugues M., and Lazdunski M. (1984) Autoradiographic localization of apamin-sensitive Ca2+-dependent K+ channels in rat brain. Eur. J. Pharmacol. 100, 135–136.

    PubMed  CAS  Google Scholar 

  17. Wolfart J., Neuhoff H., Franz O., and Roeper J. (2001) Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. J. Neurosci. 21, 3443–3456.

    PubMed  CAS  Google Scholar 

  18. Carlson J.H. and Foote S.L. (1992) Oscillation of interspike interval length in substantia nigra dopamine neurons: effects of nicotine and the dopaminergic D2 agonist LY 163502 on electrophysiological activity. Synapse 11, 229–248.

    PubMed  CAS  Google Scholar 

  19. Deniau J.M., Menetrey A., and Charpier S. (1996) The lamellar organization of the rat substantia nigra pars reticulata: segregated patterns of striatal afferents and relationship to the topography of corticostriatal projections. Neuroscience 73, 761–781.

    PubMed  CAS  Google Scholar 

  20. Bevan M.D., Booth P.A., Eaton S.A., and Bolam J.P. (1998) Selective innervation of neostriatal interneurons by a subclass of neuron in the globus pallidus of the rat. J. Neurosci. 18, 9438–9452.

    PubMed  CAS  Google Scholar 

  21. Ruskin D.N., Bergstrom D.A., Kaneoke Y., Patel B.N., Twery M.J., and Walters J.R. (1999) Multisecond oscillations in firing rate in the basal ganglia: robust modulation by dopamine receptor activation and anesthesia. J. Neurophysiol. 81, 2046–2055.

    PubMed  CAS  Google Scholar 

  22. Ruskin D.N., Bergstrom D.A., Tierney P.L., and Walters J.R. (2003) Correlated multisecond oscillations in firing rate in the basal ganglia: modulation by dopamine and the subthalamic nucleus. Neuroscience 117, 427–438.

    PubMed  CAS  Google Scholar 

  23. Fiorillo C.D. and Williams J.T. (1998) Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature 394, 78–82.

    PubMed  CAS  Google Scholar 

  24. Paladini C.A., Fiorillo C.D., Morikawa H., and Williams J.T. (2001) Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons. Nat. Neurosci. 4, 275–281.

    PubMed  CAS  Google Scholar 

  25. Wolfart J. and Roeper J. (2002) Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons. J. Neurosci. 22, 3404–3413.

    PubMed  CAS  Google Scholar 

  26. Grace A.A. and Bunney B.S. (1984) The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci. 4, 2877–2890.

    PubMed  CAS  Google Scholar 

  27. Wilson C.J. and Callaway J.C. (2000) Coupled oscillator model of the dopaminergic neuron of the substantia nigra. J. Neurophysiol. 83, 3084–3100.

    PubMed  CAS  Google Scholar 

  28. Paladini C.A., Robinson S., Morikawa H., Williams J.T., and Palmiter R.D. (2003) Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism. Proc. Natl. Acad. Sci. USA 100, 2866–2871.

    PubMed  CAS  Google Scholar 

  29. Korotkova T.M., Sergeeva O.A., Eriksson K.S., Haas H.L., and Brown R.E. (2003) Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J. Neurosci. 23, 7–11.

    PubMed  CAS  Google Scholar 

  30. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573–585.

    PubMed  CAS  Google Scholar 

  31. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., et al. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 95, 322–327.

    PubMed  Google Scholar 

  32. Goodall E., Trenchard E., and Silverstone T. (1987) Receptor blocking drugs and amphetamine anorexia in human subjects. Psychopharmacology (Berl) 92, 484–490.

    CAS  Google Scholar 

  33. Krahn D.D. and Gosnell B.A. (1989) Corticotropin-releasing hormone: possible role in eating disorders. Psychiatr. Med. 7, 235–245.

    PubMed  CAS  Google Scholar 

  34. Rodgers R.J., Halford J.C., Nunes de Souza R.L., Canto de Souza A.L., Piper D.C., Arch J.R., et al. (2001) SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur. J. Neurosci. 13, 1444–1452.

    PubMed  CAS  Google Scholar 

  35. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., et al. (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365–376.

    PubMed  CAS  Google Scholar 

  36. Nishino S., Ripley B., Overeem S., Lammers G.J., and Mignot E. (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355, 39–40.

    PubMed  CAS  Google Scholar 

  37. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., et al. (1999) Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. USA 96, 10,911–10,916.

    CAS  Google Scholar 

  38. Brown R.E., Sergeeva O., Eriksson K.S., and Haas H.L. (2001) Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology 40, 457–459.

    PubMed  CAS  Google Scholar 

  39. Brown R.E., Sergeeva O.A., Eriksson K.S., and Haas H.L. (2002) Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J. Neurosci. 22, 8850–8859.

    PubMed  CAS  Google Scholar 

  40. Eriksson K.S., Sergeeva O., Brown R.E., and Haas H.L. (2001) Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J. Neurosci. 21, 9273–9279.

    PubMed  CAS  Google Scholar 

  41. Korotkova T.M., Eriksson K.S., Haas H.L., and Brown R.E. (2002) Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul. Pept. 104, 83–89.

    PubMed  CAS  Google Scholar 

  42. Liu F.C. and Graybiel A.M. (1992) Transient calbindin-D28k-positive systems in the telencephalon: ganglionic eminence, developing striatum and cerebral cortex. J. Neurosci. 12, 674–690.

    PubMed  CAS  Google Scholar 

  43. Fadel J. and Deutch A.Y. (2002) Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111, 379–387.

    PubMed  CAS  Google Scholar 

  44. Li Y., Gao X.B., Sakurai T., and van den Pol A.N. (2002) Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron 36, 1169–1181.

    PubMed  CAS  Google Scholar 

  45. You Z.B., Chen Y.Q., and Wise R.A. (2001) Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation. Neuroscience 107, 629–639.

    PubMed  CAS  Google Scholar 

  46. Olds J. (1958) Self-stimulation of the brain. Science 127, 315–324.

    PubMed  CAS  Google Scholar 

  47. Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., et al. (2003) Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38, 701–713.

    PubMed  CAS  Google Scholar 

  48. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., and Edgar D.M. (2001) Dopaminergic role in stimulant-induced wakefulness. J. Neurosci. 21, 1787–1794.

    PubMed  CAS  Google Scholar 

  49. Reid M.S., Tafti M., Nishino S., Sampathkumaran R., Siegel J.M., and Mignot E. (1996) Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine. Brain Res. 733, 83–100.

    PubMed  CAS  Google Scholar 

  50. Okura M., Riehl J., Mignot E., and Nishino S. (2000) Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy. Neuropsychopharmacology 23, 528–538.

    PubMed  CAS  Google Scholar 

  51. Nishino S. and Mignot E. (1997) Pharmacological aspects of human and canine narcolepsy. Prog. Neurobiol. 52, 27–78.

    PubMed  CAS  Google Scholar 

  52. Horvath T.L., Peyron C., Diano S., Ivanov A., Aston-Jones G., Kilduff T.S., et al. (1999) Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol. 415, 145–159.

    PubMed  CAS  Google Scholar 

  53. Clapham D.E., Runnels L.W., and Strubing C. (2001) The TRP ion channel family. Nat. Rev. Neurosci. 2, 387–396.

    PubMed  CAS  Google Scholar 

  54. Obukhov A.G. and Nowycky M.C. (2002) TRPC4 can be activated by G-protein-coupled receptors and provides sufficient Ca(2+) to trigger exocytosis in neuroendocrine cells. J. Biol. Chem. 277, 16,172–16,178.

    CAS  Google Scholar 

  55. Sergeeva O.A., Korotkova T.M., Scherer A., Brown R.E., and Haas H.L. (2003) Co-expression of non-selective cation channels of the transient receptor potential canonical family in central aminergic neurons. J. Neurochem. 85, 1547–1552.

    PubMed  CAS  Google Scholar 

  56. Neuhoff H., Neu A., Liss B., and Roeper J. (2002) 1(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J. Neurosci. 22, 1290–1302.

    PubMed  CAS  Google Scholar 

  57. Kiyatkin E.A. and Rebec G.V. (1998) Heterogeneity of ventral tegmental area neurons: single-unit recording and iontophoresis in awake, unrestrained rats. Neuroscience 85, 1285–1309.

    PubMed  CAS  Google Scholar 

  58. Paladini C.A., Celada P., and Tepper J.M. (1999) Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo. Neuroscience 89, 799–812.

    PubMed  CAS  Google Scholar 

  59. Seutin V., Massotte L., Renette M.F., and Dresse A. (2001) Evidence for a modulatory role of Ih on the firing of a subgroup of midbrain dopamine neurons. Neuroreport 12, 255–258.

    PubMed  CAS  Google Scholar 

  60. Dabbeni-Sala F., Di Santo S., Franceschini D., Skaper S.D., and Giusti P. (2001) Melatonin protects against 6-OHDA-induced neutoxicity in rats: a role for mitochondrial complex I activity. FASEB J. 15, 164–170.

    PubMed  CAS  Google Scholar 

  61. Greenamyre J.T., Sherer T.B., Betarbet R., and Panov A.V. (2001) Complex I and Parkinson’s disease. IUBMB. Life 52, 135–141.

    PubMed  CAS  Google Scholar 

  62. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat. Neurosci. 3, 1301–1306.

    PubMed  CAS  Google Scholar 

  63. Schapira A.H., Gu M., Taanman J.W., Tabrizi S.J., Seaton T., Cleeter M., et al. (1998) Mitochondria in the etiology and pathogenesis of Parkinson’s disease. Ann. Neurol. 44, S89-S98.

    PubMed  CAS  Google Scholar 

  64. Liss B. and Roeper J. (2001) ATP-sensitive potassium channels in dopaminergic neurons: transducers of mitochondrial dysfunction. News Physiol. Sci. 16, 214–217.

    PubMed  CAS  Google Scholar 

  65. Mourre C., Ben Ari Y., Bernardi H., Fosset M., and Lazdunski M. (1989) Antidiabetic sulfonylureas: localization of binding sites in the brain and effects on the hyperpolarization induced by anoxia in hippocampal slices. Brain Res. 486, 159–164.

    PubMed  CAS  Google Scholar 

  66. Xu S.G., Prasad C., and Smith D.E. (1999) Neurons exhibiting dopamine D2 receptor immunoreactivity in the substantia nigra of the mutant weaver mouse. Neuroscience 89, 191–207.

    PubMed  CAS  Google Scholar 

  67. Liss B., Neu A., and Roeper J. (1999) The weaver mouse gain-of-function phenotype of dopaminergic midbrain neurons is determined by coactivation of wvGirk2 and K-ATP channels. J. Neurosci. 19, 8839–8848.

    PubMed  CAS  Google Scholar 

  68. Liang C.L., Sinton C.M., Sonsalla P.K., and German D.C. (1996) Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. Neurodegeneration 5, 313–318.

    PubMed  CAS  Google Scholar 

  69. Rodriguez M., Barroso-Chinea P., Abdala P., Obeso J., and Gonzalez-Hernandez T. (2001) Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in Parkinson’s disease. Exp. Neurol. 169, 163–181.

    PubMed  CAS  Google Scholar 

  70. Meyer M., Zimmer J., Seiler R.W., and Widmer H.R. (1999) GDNF increases the density of cells containing calbindin but not of cells containing calretinin in cultured rat and human fetal nigral tissue. Cell Transplant. 8, 25–36.

    PubMed  CAS  Google Scholar 

  71. Airaksinen M.S., Thoenen H., and Meyer M. (1997) Vulnerability of midbrain dopaminergic neurons in calbindin-D28k- deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice. Eur. J. Neurosci. 9, 120–127.

    PubMed  CAS  Google Scholar 

  72. Kohr G., Lambert C.E., and Mody I. (1991) Calbindin-D28K (CaBP) levels and calcium currents in acutely dissociated epileptic neurons. Exp. Brain Res. 85, 543–551.

    PubMed  CAS  Google Scholar 

  73. Baimbridge K.G., Celio M.R., and Rogers J.H. (1992) Calcium-binding proteins in the nervous system. Trends Neurosci. 15, 303–308.

    PubMed  CAS  Google Scholar 

  74. Rogers J.H. (1992) Immunohistochemical markers in rat brain: colocalization of calretinin and calbindin-D28k with tyrosine hydroxylase. Brain Res. 587, 203–210.

    PubMed  CAS  Google Scholar 

  75. German D.C., Manaye K.F., Sonsalla P.K., and Brooks B.A. (1992) Midbrain dopaminergic cell loss in Parkinson’s disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Ann. NY Acad. Sci. 648, 42–62.

    PubMed  CAS  Google Scholar 

  76. Zahm D.S. (1991) Compartments in rat dorsal and ventral striatum revealed following injection of 6-hydroxydopamine into the ventral mesencephalon. Brain Res. 552, 164–169.

    PubMed  CAS  Google Scholar 

  77. Wichmann T. and DeLong M.R. (1998) Models of basal ganglia function and pathophysiology of movement disorders. Neurosurg. Clin. N. Am. 9, 223–236.

    PubMed  CAS  Google Scholar 

  78. Ye W., Shimamura K., Rubenstein J.L., Hynes M.A., and Rosenthal A. (1998) FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 93, 755–766.

    PubMed  CAS  Google Scholar 

  79. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., et al. (1998) Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA 95, 4013–4018.

    PubMed  CAS  Google Scholar 

  80. Lebel M., Gauthier Y., Moreau A., and Drouin J. (2001) Pitx3 activates mouse tyrosine hydroxylase promoter via a high-affinity binding site. J. Neurochem. 77, 558–567.

    PubMed  CAS  Google Scholar 

  81. Van den Munckhof P., Luk K.C., Ste-Marie L., Montgomery J., Blanchet P.J., Sadikot A.F., et al. (2003) Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development 130, 2535–2542.

    PubMed  Google Scholar 

  82. Nunes I., Tovmasian L.T., Silva R.M., Burke R.E., and Goff S.P. (2003) Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc. Natl. Acad. Sci. USA 100, 4245–4250.

    PubMed  CAS  Google Scholar 

  83. Park M., Kitahama K., Geffard M., and Maeda T. (2000) Postnatal development of the dopaminergic neurons in the rat mesencephalon. Brain Dev. 22 Suppl 1, S38-S44.

    PubMed  Google Scholar 

  84. Smidt M.P., van Schaick H.S., Lanctot C., Tremblay J.J., Cox J.J., van der Kleij A.A., et al. (1997) A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl. Acad. Sci. USA 94, 13,305–13,310.

    CAS  Google Scholar 

  85. Szeto D.P., Rodriguez-Esteban C., Ryan A.K., O’Connell S.M., Liu F., Kioussi C., et al. (1999) Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes Dev. 13, 484–494.

    PubMed  CAS  Google Scholar 

  86. Muccielli M.L., Martinez S., Pattyn A., Goridis C., and Brunet J.F. (1996) Otlx2, an Otx-related homeobox gene expressed in the pituitary gland and in a restricted pattern in the forebrain. Mol. Cell Neurosci. 8, 258–271.

    PubMed  CAS  Google Scholar 

  87. Westmoreland J.J., McEwen J., Moore B.A., Jin Y., and Condie B.G. (2001) Conserved function of Caenorhabditis elegans UNC-30 and mouse Pitx2 in controlling GABAergic neuron differentiation. J. Neurosci. 21, 6810–6819.

    PubMed  CAS  Google Scholar 

  88. Simon H.H., Saueressig H., Wurst W., Goulding M.D., and O’Leary D.D. (2001) Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J. Neurosci. 21, 3126–3134.

    PubMed  CAS  Google Scholar 

  89. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045–2047.

    PubMed  CAS  Google Scholar 

  90. Carr D.B. and Sesack S.R. (2000) Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 20, 3864–3873.

    PubMed  CAS  Google Scholar 

  91. Steffensen S.C., Svingos A.L., Pickel V.M., and Henriksen S.J. (1998) Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J. Neurosci. 18, 8003–8015.

    PubMed  CAS  Google Scholar 

  92. Bonci A. and Malenka R.C. (1999) Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area. J. Neurosci. 19, 3723–3730.

    PubMed  CAS  Google Scholar 

  93. Johnson S.W. and North R.A. (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12, 483–488.

    PubMed  CAS  Google Scholar 

  94. Szabo B., Siemes S., and Wallmichrath I. (2002) Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur. J. Neurosci. 15, 2057–2061.

    PubMed  Google Scholar 

  95. Yin R. and French E.D. (2000) A comparison of the effects of nicotine on dopamine and nondopamine neurons in the rat ventral tegmental area: an in vitro electrophysiological study. Brain Res. Bull. 51, 507–514.

    PubMed  CAS  Google Scholar 

  96. Mansvelder H.D. and McGehee D.S. (2000) Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27, 349–357.

    PubMed  CAS  Google Scholar 

  97. Klink R., de Kerchove d.A., Zoli M., and Changeux J.P. (2001) Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci. 21, 1452–1463.

    PubMed  CAS  Google Scholar 

  98. Wooltorton J.R., Pidoplichko V.I., Broide R.S., and Dani J.A. (2003) Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J. Neurosci. 23, 3176–3185.

    PubMed  CAS  Google Scholar 

  99. Morens D.M., Grandinetti A., Reed D., White L.R., and Ross G.W. (1995) Cigarette smoking and protection from Parkinson’s disease: false association or etiologic clue? Neurology 45, 1041–1051.

    PubMed  CAS  Google Scholar 

  100. Ryan R.E., Ross S.A., Drago J., and Loiacono R.E. (2001) Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice. Br. J. Pharmacol. 132, 1650–1656.

    PubMed  CAS  Google Scholar 

  101. Zhou F.M., Wilson C., and Dani J.A. (2003) Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems. Neuroscientist 9, 23–36.

    PubMed  CAS  Google Scholar 

  102. Steffensen S.C., Lee R.S., Stobbs S.H., and Henriksen S.J. (2001) Responses of ventral tegmental area GABA neurons to brain stimulation reward. Brain Res. 906, 190–197.

    PubMed  CAS  Google Scholar 

  103. Kiyatkin E.A. and Rebec G.V. (2001) Impulse activity of ventral tegmental area neurons during heroin self-administration in rats. Neuroscience 102, 565–580.

    PubMed  CAS  Google Scholar 

  104. Niijima K. and Yoshida M. (1982) Electrophysiological evidence for branching nigral projections to pontine reticular formation, superior colliculus and thalamus. Brain Res. 239, 279–282.

    PubMed  CAS  Google Scholar 

  105. Evans N.A., Groarke D.A., Warrack J., Greenwood C.J., Dodgson K., Milligan G., et al. (2001) Visualizing differences in ligand-induced beta-arrestin-GFP interactions and trafficking between three recently characterized G protein-coupled receptors. J. Neurochem. 77, 476–485.

    PubMed  CAS  Google Scholar 

  106. Blandini F., Nappi G., Tassorelli C., and Martignoni E. (2000) Functional changes of the basal ganglia circuitry in Parkinson’s disease. Prog. Neurobiol. 62, 63–88.

    PubMed  CAS  Google Scholar 

  107. Diaz M.R., Barroso-Chinea P., Acevedo A., and Gonzalez-Hernandez T. (2003) Effects of dopaminergic cell degeneration on electrophysiological characteristics and GAD65/GAD67 expression in the substantia nigra: Different action on GABA cell subpopulations. Mov. Disord. 18, 254–266.

    PubMed  Google Scholar 

  108. Llorens-Cortes C., Pollard H., and Schwartz J.C. (1979) Localization of opiate receptors in substantia nigra evidence by lesion studies. Neurosci. Lett. 12, 165–170.

    PubMed  CAS  Google Scholar 

  109. Cameron D.L., Wessendorf M.W., and Williams J.T. (1997) A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience 77, 155–166.

    PubMed  CAS  Google Scholar 

  110. Gonzalez-Hernandez T., Barroso-Chinea P., Acevedo A., Salido E., and Rodriguez M. (2001) Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons. Eur. J. Neurosci. 13, 57–67.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Neurophysiology, Heinrich Heine University, D-40001, Duesseldorf, Germany

    Tatiana M. Korotkova, Alexei A. Ponomarenko, Ritchie E. Brown & Helmut L. Haas

  2. Department of Psychiatry, Harvard Medical School and VA Medical Center, Brockton, MA

    Tatiana M. Korotkova, Alexei A. Ponomarenko, Ritchie E. Brown & Helmut L. Haas

Authors
  1. Tatiana M. Korotkova
    View author publications

    Search author on:PubMed Google Scholar

  2. Alexei A. Ponomarenko
    View author publications

    Search author on:PubMed Google Scholar

  3. Ritchie E. Brown
    View author publications

    Search author on:PubMed Google Scholar

  4. Helmut L. Haas
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Tatiana M. Korotkova.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Korotkova, T.M., Ponomarenko, A.A., Brown, R.E. et al. Functional diversity of ventral midbrain dopamine and GABAergic neurons. Mol Neurobiol 29, 243–259 (2004). https://doi.org/10.1385/MN:29:3:243

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1385/MN:29:3:243

Index Entries